XFOR
#3129
X4 Pharmaceuticals, Inc. - Common Stock
4.0 5 USD
-0.08%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-8.16%
Variación mensual
-0.74%
Variación en los últimos 6 meses
+36.36%
Cambio anual
+36.36%
Cierres anteriores
4.4 1
Open
4.0 5
Mínimo
4.0 5
High
4.0 5
Volumen
66
Financials
- Market Capitalization 381.99 M
- Employee 45
- Founded 2019
- CEO N/A
- Website www.x4pharma.com
- Headquarter Delaware, United States
- FIGI BBG001J1CYH8
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.14
Relación precio/flujo de caja
26.03
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3109 |  AUTL Autolus Therapeutics plc - American Depositary Shares | 1.48 USD | -8.07% | -9.20% | -8.64% | -44.36% | 393.91 M USD | ||
| 3121 |  LRMR Larimar Therapeutics, Inc. - Common Stock | 3.73 USD | -12.85% | +11.34% | +6.27% | +6.27% | 387.48 M USD | ||
| 3133 |  AVIR Atea Pharmaceuticals, Inc. - common stock | 4.74 USD | -5.01% | -3.27% | +6.28% | +47.66% | 379.33 M USD | ||
| 3147 |  FENC Fennec Pharmaceuticals Inc. - Common Stock | 10.75 USD | +2.48% | -0.46% | +18.78% | +21.47% | 373.42 M USD |